Add Company
Join Now

Biosynexus Incorporated Revenue and Competitors

License our Company Data API

USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Biosynexus Incorporated's estimated annual revenue is currently $775k per year.(i)
  • Biosynexus Incorporated's estimated revenue per employee is $155,000

Employee Data

  • Biosynexus Incorporated has 5 Employees.(i)
  • Biosynexus Incorporated grew their employee count by 0% last year.

Biosynexus Incorporated's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$81.4M37540%N/AN/A
#2
$16.9M10922%N/AN/A
#3
$156.1M120-70%$145MN/A
#4
$2.9M37-24%$150MN/A
#5
$1.3M170%$459.5MN/A
#6
$49.2M25415%$180.7MN/A
#7
$7M45-2%N/AN/A
#8
$256.3M8409%$168.5MN/A
#9
$10.1M655%N/AN/A
#10
$16.1M1049%N/AN/A
Add Company

What Is Biosynexus Incorporated?

Biosynexus Incorporated is a biopharmaceutical company that is developing a monoclonal antibody, pagibaximab, to prevent staphylococcal sepsis in very low birth weight (VLBW) infants in the setting of the neonatal intensive care unit (NICU). The company has two additional product candidates: lysostaphin for the treatment of life threatening staphylococcal infections and nisin a topical cream for treating serious skin infections. Biosynexus' mission is bringing products to the market for the prevention and treatment of bacterial infections with emphasis on the prevention of staphylococcal infections in VLBW infants.

keywords:N/A

N/A

Total Funding

5

Number of Employees

$775k

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.5M5-17%$76.7M
#2
$0.7M5N/AN/A
#3
$0.3M5N/AN/A
#4
$0.5M5N/AN/A
#5
$0.5M5N/AN/A